title: Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet).
authors.affiliation: Department of Medicine, University of Toronto, Canada.
authors.forename: S L
authors.initials: SL
authors.lastname: Walmsley
authors.forename: E
authors.initials: E
authors.lastname: Chew
authors.forename: S E
authors.initials: SE
authors.lastname: Read
authors.forename: H
authors.initials: H
authors.lastname: Vellend
authors.forename: I
authors.initials: I
authors.lastname: Salit
authors.forename: A
authors.initials: A
authors.lastname: Rachlis
authors.forename: M M
authors.initials: MM
authors.lastname: Fanning
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000150:complications / Q000188:drug therapy*; D017245:Foscarnet; D006801:Humans; D007119:Immunoblastic Lymphadenopathy / Q000150:complications; D008297:Male; D008875:Middle Aged; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D010746:Phosphonoacetic Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D012008:Recurrence; D012173:Retinitis / Q000150:complications / Q000188:drug therapy*
chemical_list: D000998:Antiviral Agents; D009943:Organophosphorus Compounds; D017245:Foscarnet; D010746:Phosphonoacetic Acid